Calcium-Phosphorus Product Is Associated with Adverse Prognosis in Hospitalized Patients with Heart Failure and Chronic Kidney Disease-Reference-Cited by-同舟云学术

Calcium-Phosphorus Product Is Associated with Adverse Prognosis in Hospitalized Patients with Heart Failure and Chronic Kidney Disease

Published:2024-01-31 Issue:1 Volume:65 Page:84-93
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Abe Satoshi¹,Yoshihisa Akiomi¹²,Oohara Himika¹,Sugawara Yukiko¹,Sato Yu¹,Misaka Tomofumi¹,Sato Takamasa¹,Oikawa Masayoshi¹,Kobayashi Atsushi¹,Yamaki Takayoshi¹,Nakazato Kazuhiko¹,Takeishi Yasuchika¹

Affiliation:

1. Department of Cardiovascular Medicine, Fukushima Medical University

2. Department of Clinical Laboratory Sciences, Fukushima Medical University School of Health Science

Publisher

International Heart Journal (Japanese Heart Journal)

Link

https://www.jstage.jst.go.jp/article/ihj/65/1/65_23-203/_pdf

Reference62 articles.

1. 1. O'Neill WC. The fallacy of the calcium-phosphorus product. Kidney Int 2007; 72: 792-6.

2. 2. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-17.

3. 3. Cianciolo G, La Manna G, Donati G, et al. Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index? Blood Purif 2010; 29: 13-22.

4. 4. Suzuki Y, Matsumoto N, Yoda S, Amano Y, Okumura Y. Coronary artery calcium score: Current status of clinical application and how to handle the results. J Cardiol 2022; 79: 567-71.

5. 5. Nakanishi R, Osawa K, Kurata A, Miyoshi T. Role of coronary computed tomography angiography (CTA) post the ISCHEMIA trial: Precision prevention based on coronary CTA-derived coronary atherosclerosis. J Cardiol 2022; 79: 572-80.